Shared on 21 Sep 25
Fair value Decreased 20%Despite a notable improvement in net profit margin and a sharply lower future P/E ratio indicating stronger profitability and valuation, the consensus analyst price target for Oncoclínicas do Brasil Serviços Médicos has been revised downward from R$4.49 to R$3.59. What's in the News Special/Extraordinary Shareholders Meetings scheduled for Sep 09, 2025, and Oct 08, 2025, at the company's São Paulo location.
Shared on 06 Sep 25
With both the discount rate and future P/E ratio remaining effectively unchanged, analysts have kept their price target for Oncoclínicas do Brasil Serviços Médicos steady at R$4.49. What's in the News Oncoclínicas do Brasil Serviços Médicos S.A. was removed from the Brazil IBRX Index.
Shared on 23 Apr 25
Fair value Decreased 22%AnalystConsensusTarget has increased revenue growth from 9.7% to 12.2% and increased future PE multiple from 17.0x to 20.2x.